VisionSys AI (NASDAQ: VSA) announced on April 27, 2026 that it is in advanced discussions for a proposed strategic investment of $90 million at $1.50 per share. The company plans to use proceeds to accelerate its BCI algorithms, AI-powered healthcare and biotechnology products, hardware/software integration, international expansion, and working capital.

The proposal is described as intended to improve liquidity and support commercialization of non-invasive BCI devices with later expansion into serious medical applications if regulatory progress is achieved.